←Back to structures
S2_012_000_R2_scaffold_0_prodigal-single.1__X__X__01097
Bact-VirS2_012_000_R2_scaffold_0_prodigal-single.1__X__X__01097
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 86-213
Domain cluster:
rep: MN270258.1__QGJ85309.1__X__00082__D64-191
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF11393.15 best | T4BSS_DotI_IcmL | 57.4 | 1.80e-15 | 99.2% | 70.0% |
CATH (58)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4ec6A00 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 66.0 | 7.09e-01 | 100.0% | 95.4% |
| 4kz1A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.82 | 77.0 | 7.59e-01 | 100.0% | 97.8% |
| 3ub1D02 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 60.0 | 6.32e-01 | 100.0% | 85.1% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.81 | 76.0 | 7.42e-01 | 100.0% | 92.8% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.80 | 75.0 | 7.23e-01 | 100.0% | 91.7% |
| 5i97C00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.77 | 72.0 | 7.08e-01 | 100.0% | 97.8% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 63.0 | 6.00e-01 | 100.0% | 78.6% |
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 68.0 | 6.76e-01 | 100.0% | 99.2% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 69.0 | 6.62e-01 | 100.0% | 91.5% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 67.0 | 6.28e-01 | 98.4% | 100.0% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 62.0 | 6.17e-01 | 99.2% | 86.9% |
| 1vqqA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.73 | 59.0 | 6.30e-01 | 96.9% | 100.0% |
| 3k0zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 63.0 | 5.95e-01 | 100.0% | 78.5% |
| 1of5B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 64.0 | 6.46e-01 | 100.0% | 95.3% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.57e-01 | 100.0% | 95.4% |
| 3mg1B02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 61.0 | 6.17e-01 | 97.7% | 91.2% |
| 2bngC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 59.0 | 5.75e-01 | 100.0% | 79.3% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 65.0 | 6.44e-01 | 100.0% | 94.7% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 64.0 | 6.32e-01 | 100.0% | 92.5% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 62.0 | 6.38e-01 | 100.0% | 98.3% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 66.0 | 6.00e-01 | 100.0% | 90.4% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 65.0 | 6.19e-01 | 100.0% | 85.1% |
| 1wnhA01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 49.0 | 5.47e-01 | 100.0% | 91.0% |
| 1tp6A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 63.0 | 6.42e-01 | 99.2% | 98.4% |
| 2lyxA00 | 3.10.450.390 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Protein of unknown function DUF3889 | 0.70 | 42.0 | 4.87e-01 | 96.9% | 85.1% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 61.0 | 6.14e-01 | 100.0% | 92.9% |
| 1tuhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 61.0 | 6.08e-01 | 100.0% | 90.1% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 5.80e-01 | 100.0% | 85.9% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 6.19e-01 | 100.0% | 90.5% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 6.28e-01 | 100.0% | 92.1% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 5.81e-01 | 100.0% | 77.4% |
| 3b7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 60.0 | 6.16e-01 | 100.0% | 100.0% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 62.0 | 6.13e-01 | 100.0% | 92.5% |
| 3eyrA00 | 3.15.10.40 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Uncharacterised protein PF07273 family, DUF1439 | 0.68 | 49.0 | 4.44e-01 | 100.0% | 55.6% |
| 2r4iA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 59.0 | 6.05e-01 | 100.0% | 95.9% |
| 7f13A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 58.0 | 5.64e-01 | 100.0% | 82.6% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 59.0 | 5.92e-01 | 100.0% | 93.8% |
| 1of5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 62.0 | 5.82e-01 | 100.0% | 83.1% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 58.0 | 5.82e-01 | 98.4% | 90.2% |
| 3ke7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 57.0 | 5.67e-01 | 99.2% | 88.0% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.66 | 44.0 | 4.03e-01 | 100.0% | 50.6% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 59.0 | 5.97e-01 | 99.2% | 97.6% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 57.0 | 5.74e-01 | 99.2% | 91.5% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 57.0 | 5.72e-01 | 99.2% | 93.0% |
| 2i9wA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 58.0 | 5.20e-01 | 96.1% | 76.1% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 53.0 | 5.48e-01 | 100.0% | 97.5% |
| 1s5aB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 55.0 | 5.35e-01 | 100.0% | 87.4% |
| 2obdA01 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.62 | 54.0 | 4.17e-01 | 100.0% | 43.1% |
| 1wnhA02 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 49.0 | 5.04e-01 | 100.0% | 91.7% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 52.0 | 5.18e-01 | 100.0% | 91.9% |
| 3fgyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 48.0 | 4.80e-01 | 100.0% | 87.4% |
| 1bp1A01 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.55 | 49.0 | 4.36e-01 | 100.0% | 68.9% |
| 1gkuB07 | 2.60.510.20 | Mainly Beta › Sandwich › EV matrix protein fold › | 0.54 | 33.0 | 3.65e-01 | 82.0% | 75.5% |
| 3h4zB03 | 3.15.10.50 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › | 0.54 | 49.0 | 4.27e-01 | 100.0% | 66.0% |
| 2xsgB01 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.53 | 44.0 | 3.39e-01 | 89.1% | 78.6% |
| 1af6A00 | 2.40.170.10 | Mainly Beta › Beta Barrel › Maltoporin; Chain A › Porin, LamB type | 0.51 | 38.0 | 2.68e-01 | 77.3% | 86.9% |
| 1ut7B01 | 2.170.150.80 | Mainly Beta › Beta Complex › Metal Binding Protein, Guanine Nucleotide Exchange Factor; Chain A › NAC domain | 0.50 | 36.0 | 3.68e-01 | 73.4% | 88.0% |
| 2amhA00 | 3.90.950.10 | Alpha Beta › Alpha-Beta Complex › Maf protein › | 0.50 | 40.0 | 3.52e-01 | 85.9% | 93.3% |
ECOD (76)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1558628 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.95 | 92.0 | 8.89e-01 | 100.0% | 94.3% |
| 1674783 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.92 | 89.0 | 8.60e-01 | 100.0% | 92.1% |
| 1558627 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.89 | 86.0 | 8.35e-01 | 100.0% | 97.1% |
| 3291726 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.86 | 78.0 | 7.25e-01 | 99.2% | 79.2% |
| 3952458 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.86 | 75.0 | 7.52e-01 | 100.0% | 90.8% |
| 3941713 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.84 | 79.0 | 7.64e-01 | 99.2% | 97.9% |
| 3950026 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.84 | 75.0 | 7.43e-01 | 100.0% | 90.3% |
| 3958465 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.84 | 74.0 | 6.96e-01 | 97.7% | 79.3% |
| 3962486 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.83 | 76.0 | 7.05e-01 | 100.0% | 79.2% |
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.83 | 72.0 | 7.45e-01 | 100.0% | 97.5% |
| 3958251 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.82 | 74.0 | 6.87e-01 | 100.0% | 79.2% |
| 4254866 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.81 | 69.0 | 7.04e-01 | 99.2% | 92.0% |
| 4152363 | 243.1.1.115 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29733 | 0.81 | 71.0 | 7.24e-01 | 100.0% | 95.9% |
| 4865157 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.81 | 67.0 | 7.03e-01 | 100.0% | 95.7% |
| 3278986 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.80 | 73.0 | 6.79e-01 | 100.0% | 79.4% |
| 4352488 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.80 | 76.0 | 7.19e-01 | 100.0% | 89.9% |
| 4373837 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.80 | 75.0 | 7.27e-01 | 100.0% | 95.0% |
| 3961892 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.78 | 73.0 | 7.05e-01 | 100.0% | 90.7% |
| 4472109 | 243.1.1.103 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF30257 | 0.77 | 63.0 | 6.51e-01 | 100.0% | 90.8% |
| 4561192 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.77 | 46.0 | 5.73e-01 | 99.2% | 96.2% |
| 1790173 | 243.1.1.39 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TraH_VirB8-like | 0.76 | 69.0 | 6.97e-01 | 100.0% | 96.9% |
| 3736480 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 69.0 | 6.45e-01 | 100.0% | 91.0% |
| 3193103 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 69.0 | 5.89e-01 | 100.0% | 92.9% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.74 | 66.0 | 6.73e-01 | 100.0% | 97.6% |
| 3970236 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 67.0 | 6.52e-01 | 100.0% | 89.9% |
| 4193401 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.73 | 57.0 | 6.15e-01 | 96.9% | 95.5% |
| 4582733 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 56.0 | 5.66e-01 | 96.9% | 79.2% |
| 3296374 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 63.0 | 5.77e-01 | 100.0% | 70.9% |
| 3808862 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.73 | 66.0 | 6.43e-01 | 100.0% | 88.4% |
| 4283272 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.73 | 69.0 | 6.17e-01 | 100.0% | 83.5% |
| 3519929 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.73 | 64.0 | 6.39e-01 | 100.0% | 91.5% |
| 4074364 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 57.0 | 5.70e-01 | 97.7% | 80.8% |
| 5059048 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.73 | 64.0 | 6.58e-01 | 99.2% | 97.6% |
| 3970009 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 68.0 | 6.11e-01 | 100.0% | 84.6% |
| 3056323 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.72 | 68.0 | 6.27e-01 | 100.0% | 89.2% |
| 4664562 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.72 | 67.0 | 5.98e-01 | 100.0% | 86.3% |
| 3833801 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.72 | 45.0 | 5.47e-01 | 98.4% | 100.0% |
| 5022156 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.71 | 67.0 | 6.51e-01 | 100.0% | 92.8% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.71 | 62.0 | 6.38e-01 | 100.0% | 98.3% |
| 3959349 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.71 | 63.0 | 6.25e-01 | 99.2% | 90.3% |
| 4608992 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.71 | 66.0 | 6.11e-01 | 100.0% | 91.1% |
| 3517998 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.71 | 66.0 | 5.60e-01 | 100.0% | 81.0% |
| 5009713 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.71 | 66.0 | 6.09e-01 | 100.0% | 93.8% |
| 135548 | 243.1.1.19 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF3804 | 0.70 | 61.0 | 6.13e-01 | 100.0% | 92.2% |
| 3727055 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.70 | 65.0 | 6.21e-01 | 100.0% | 90.3% |
| 4676601 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.70 | 65.0 | 5.90e-01 | 100.0% | 85.8% |
| 3826602 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.70 | 62.0 | 6.02e-01 | 100.0% | 87.1% |
| 4884000 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.70 | 63.0 | 5.89e-01 | 96.1% | 91.0% |
| 3278323 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.70 | 62.0 | 6.17e-01 | 100.0% | 92.3% |
| 2722108 | 243.1.1.67 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Cds6_C | 0.70 | 60.0 | 6.14e-01 | 99.2% | 96.0% |
| 4927181 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.70 | 62.0 | 6.25e-01 | 100.0% | 96.1% |
| 3407993 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.69 | 65.0 | 5.70e-01 | 100.0% | 83.3% |
| 3182613 | 243.1.1.44 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MBA1 | 0.69 | 64.0 | 5.27e-01 | 99.2% | 57.7% |
| 137905 | 883.1.1.5 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › DUF1439 | 0.69 | 49.0 | 4.43e-01 | 100.0% | 55.0% |
| 3828738 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.69 | 63.0 | 5.87e-01 | 100.0% | 81.3% |
| 3731745 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.69 | 62.0 | 5.78e-01 | 100.0% | 78.8% |
| 5003871 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.68 | 63.0 | 6.15e-01 | 100.0% | 95.0% |
| 3432106 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.68 | 47.0 | 4.84e-01 | 99.2% | 73.8% |
| 4958928 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 58.0 | 6.06e-01 | 93.0% | 100.0% |
| 3253090 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 55.0 | 5.87e-01 | 97.7% | 99.1% |
| 3213522 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.68 | 62.0 | 5.86e-01 | 100.0% | 91.3% |
| 137634 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.67 | 59.0 | 5.92e-01 | 100.0% | 93.8% |
| 3696055 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.67 | 58.0 | 5.73e-01 | 100.0% | 88.9% |
| 3466996 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.63 | 50.0 | 5.19e-01 | 96.9% | 90.0% |
| 4957500 | 283.2.1.0 ↗ | a+b duplicates or obligate multimers › Creatinase/aminopeptidase-like › gpW/gp25-like › gpW/gp25-like | 0.62 | 35.0 | 4.05e-01 | 81.2% | 75.8% |
| 3511571 | 883.1.1.2 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP_C | 0.60 | 56.0 | 4.36e-01 | 100.0% | 49.4% |
| 3230449 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.60 | 54.0 | 5.10e-01 | 100.0% | 85.2% |
| 3763243 | 883.1.1.15 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP+LBP_BPI_CETP_C | 0.59 | 54.0 | 3.66e-01 | 100.0% | 28.5% |
| 3891705 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.58 | 50.0 | 4.25e-01 | 100.0% | 58.0% |
| 4497770 | 883.1.1.15 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP+LBP_BPI_CETP_C | 0.57 | 51.0 | 3.49e-01 | 100.0% | 27.5% |
| 3957386 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.57 | 45.0 | 4.04e-01 | 100.0% | 60.0% |
| 3813082 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.57 | 40.0 | 3.53e-01 | 71.9% | 69.7% |
| 3817253 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.56 | 41.0 | 3.76e-01 | 74.2% | 75.3% |
| 3653384 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.56 | 39.0 | 3.71e-01 | 71.9% | 71.6% |
| 3827979 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.54 | 38.0 | 3.79e-01 | 74.2% | 85.6% |
| 3806226 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.51 | 37.0 | 3.46e-01 | 74.2% | 80.0% |
D2
medium
residues 1-82